MDLN · Categories · Offerings
MDLN - Public offerings
Medline Inc. (MDLN) public offerings - real-time wire coverage filtered to Offerings only.
Recent Offerings for MDLN
- Medline Inc. announces closing of upsized secondary offering of Class A common stockNORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei
- Medline Inc. announces pricing of upsized secondary offering of Class A common stockNORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. The offering is expected to close on May 28, 2026, subject to customary closing conditions. M
- Medline Inc. announces launch of secondary offering of Class A common stockNORTHFIELD, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") have commenced an underwritten public offering of 60,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline's Class A common stock. Medline is not selling any sha
- Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, TexasGroundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growthNORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced during a groundbreaking event this week that it plans to expand its national network of 45 distribution centers across the U.S. by constructing a new 1.2 million sq. ft. distribution center in Midlothian, Texas. The distribution center is to be fully operational in Q2 of 2027 and is the first new DC announced by Medline in 2026 and after its initial public offering in December of last year.
- Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional sharesNORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not
- Medline Inc. announces pricing of secondary offering of class A common stockNORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. The offering is expected to close on March 10, 2026, subj
- Medline Inc. announces launch of secondary offering of Class A common stockNORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") have commenced an underwritten public offering of 75,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Med
- Medline Reports Fourth Quarter and Full Year 2025 ResultsDelivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of c
- Medline Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesNORTHFIELD, Ill., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized initial public offering of 248,439,654 shares of its Class A common stock at a public offering price of $29.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 32,405,172 shares of Class A common stock. Medline intends to use the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities and the remainder for general corporate purposes and to bear the expenses of the offering. Medline intends to